About Cancer Immunotherapy
Our cancer care programme is built on cell-based immunotherapy — harnessing the body’s own immune cells to recognise and target cancerous cells. Dendritic Cell Therapy (DCT) and Natural Killer (NK) Cell Therapy are offered as specialised, individually prepared treatments.
How Our Programme Works
Dendritic Cells (DCs): Specialised immune cells that activate the body’s defense system by presenting antigens to T cells, playing a key role in treating cancer.
Natural Killer (NK) Cells: Powerful immune cells that target and eliminate virus-infected and cancerous cells, offering a natural defense against disease.
Specific Treatment Pathways
Cancer Immunotherapy
Cell-based immunotherapy that activates the body’s own immune defense against cancer.
Dendritic Cell Therapy
Specialised immune cells that activate the body’s defense system by presenting antigens to T cells.
NK Cell Therapy
Powerful immune cells that target and eliminate virus-infected and cancerous cells.
T Cell Therapy
Therapies that harness T cells to recognise and respond to cancer antigens.
Explore This Treatment
Speak with our medical team to review diagnostic records and assess protocol eligibility.
GMP Protocol • ISO Class 5 Cleanroom